RE:RE:Why do small biotechs price spike up ?Mil_Man54 wrote: Too bad FSD doesn't follow any market trends and doesn't have enough money anyways to complete even one trial....but you keep glossing over that FACT Rosenberg.
And they need to stop doing this. Did they not just do this within the past year? Plus did you notice the price.....$1.30???? Here are most hard working shareholders sitting at well over $50 SP in the hole, but their shareholder value sits at $1.30. You cannot make this up...all fact
"FSD also announces the grant of stock options to directors and officers of the Company to purchase up to an aggregate of 2,000,000 Class B subordinate voting shares in accordance with the Company’s stock option plan and subject to vesting terms. The options are exercisable at a price of C$1.30 per share and will expire five years from the date of grant. Certain Independent directors were granted 400,000 PSU’s."